Related Experiment Video
Updated: Aug 16, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections
1Infectious Diseases Division, Naval Medical Center San Diego, San Diego, CA 92134, USA. NFCrum@nmcsd.med.navy.mil
Abstract:
The number of community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections is rapidly increasing. Most CA-MRSA infections are localized soft tissue infections; however, severe life-threatening infections have been occasionally described. This report serves to increase the awareness of severe CA-MRSA infections by presenting a fulminant CA-MRSA infection with sepsis, endocarditis, septic pulmonary emboli, and extensive soft tissue and bone destruction. A review of the literature revealed 14 cases of severe CA-MRSA infections with a median age of 13 y; 93% had no underlying medical condition. Only 1 case was initially treated with antibiotics effective for MRSA. The fatality rate was 64%, and 40% of patients who survived had significant disabilities.
Insights
Community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are rising. Severe CA-MRSA cases, often in young, healthy individuals, show high mortality and disability rates, highlighting the need for prompt, appropriate treatment.
Area of Science:
- Infectious Diseases
- Bacteriology
- Public Health
Background:
- Community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are increasing globally.
- While typically causing localized soft tissue infections, severe, invasive CA-MRSA disease is emerging.
- Prompt recognition and effective antibiotic treatment are crucial for managing MRSA infections.
Observation:
- This case report details a fulminant CA-MRSA infection involving sepsis, endocarditis, septic pulmonary emboli, and extensive tissue/bone destruction.
- A literature review identified 14 severe CA-MRSA cases, predominantly in adolescents (median age 13 years) with no prior medical conditions.
- Critically, only one patient received initial MRSA-effective antibiotics.
Findings:
- Severe CA-MRSA infections exhibit a high fatality rate of 64%.
- Among survivors, 40% experienced significant long-term disabilities.
- Delayed or inappropriate antibiotic therapy appears to be a common factor in severe outcomes.
Implications:
- Increased awareness of severe CA-MRSA presentations is vital for clinicians.
- Early diagnosis and administration of MRSA-targeted antibiotics are critical to improve patient outcomes.
- Further research into risk factors and optimal treatment strategies for severe CA-MRSA is warranted.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance